Swiss National Bank Has $3.12 Million Stock Holdings in AdaptHealth Corp. (NASDAQ:AHCO)

Swiss National Bank raised its stake in AdaptHealth Corp. (NASDAQ:AHCO – Get Rating) by 2.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 162,400 shares of the company’s stock after acquiring an additional 3,200 shares during the period. Swiss National Bank owned approximately 0.12% of AdaptHealth worth $3,121,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the business. Arizona State Retirement System raised its holdings in shares of AdaptHealth by 4.0% during the 4th quarter. Arizona State Retirement System now owns 18,976 shares of the company’s stock worth $365,000 after buying an additional 730 shares in the last quarter. State Board of Administration of Florida Retirement System raised its holdings in shares of AdaptHealth by 7.5% during the 4th quarter. State Board of Administration of Florida Retirement System now owns 14,166 shares of the company’s stock worth $272,000 after buying an additional 990 shares in the last quarter. Duality Advisers LP acquired a new position in shares of AdaptHealth during the 4th quarter worth $1,267,000. Commonwealth Equity Services LLC raised its holdings in shares of AdaptHealth by 12.9% during the 4th quarter. Commonwealth Equity Services LLC now owns 32,028 shares of the company’s stock worth $615,000 after buying an additional 3,664 shares in the last quarter. Finally, Lisanti Capital Growth LLC acquired a new position in shares of AdaptHealth during the 4th quarter worth $2,701,000. Institutional investors and hedge funds own 86.33% of the company’s stock.

AdaptHealth Trading Up 2.9 %

Shares of AdaptHealth stock opened at $11.36 on Tuesday. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.97 and a current ratio of 1.23. AdaptHealth Corp. has a 52 week low of $10.00 and a 52 week high of $27.48. The stock has a 50 day moving average price of $12.16 and a two-hundred day moving average price of $17.48. The stock has a market capitalization of $1.52 billion, a PE ratio of 94.67, a price-to-earnings-growth ratio of 0.83 and a beta of 0.66.

AdaptHealth (NASDAQ:AHCO – Get Rating) last issued its quarterly earnings results on Monday, February 27th. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.30). The business had revenue of $780.28 million for the quarter, compared to the consensus estimate of $787.96 million. AdaptHealth had a return on equity of 3.17% and a net margin of 1.44%. As a group, equities analysts anticipate that AdaptHealth Corp. will post 0.68 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently commented on AHCO shares. Stifel Nicolaus cut AdaptHealth from a “buy” rating to a “hold” rating and lowered their price target for the stock from $18.00 to $11.00 in a report on Tuesday, May 9th. SVB Securities decreased their price target on AdaptHealth from $30.00 to $23.00 in a research note on Wednesday, March 1st. Bank of America cut AdaptHealth from a “buy” rating to a “neutral” rating and decreased their price target for the company from $21.00 to $12.00 in a research note on Tuesday, May 9th. TheStreet cut AdaptHealth from a “c-” rating to a “d+” rating in a research note on Thursday, April 6th. Finally, Royal Bank of Canada decreased their target price on AdaptHealth from $24.00 to $18.00 in a research note on Thursday, May 11th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $18.92.

About AdaptHealth

(Get Rating)

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs.